News
Scientists have created a lifelike model of Amyotrophic Lateral Sclerosis (ALS), a type of motor neuron disease, using cells ...
After three long months, on Aug. 18, Nesbit's Lanes held a celebration marking its grand reopening. Now, a fundraiser for ...
This year's ALS Nexus conference allowed the community to connect with each other, celebrate recent advances, and share hope ...
Attaching a molecule dubbed KDS12025 to hemoglobin improved the protein's ability to neutralize abberant reactive oxygen species in the brain ...
A new landmark BCI study led by Stanford Medicine neuroscientists demonstrates a brain-computer interface capable of decoding ...
A compound normally associated with red blood cells may also play a game-changing antioxidant role in the brain, a study has ...
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that causes the gradual loss of motor neurons in the brain and spinal cord, leading to muscle weakness, paralysis, and ...
The influencer, 36, has partnered with adaptive clothing brand Silverts to launch a chic collection for young disabled people ...
The Gilded Age actress, 73, stepped out at the re-opening of Mamma Mia! at New York City's Winter Garden Theatre on Monday, ...
2d
Stockhead on MSNNeurizon’s ALS drug shows safety and extended survival in open-label extension study
Neurizon Therapeutics has reported positive topline results from an open-label extension study of its lead candidate NUZ-001 ...
Robin Leaper lost her voice to ALS. Artificial Intelligence has given her back the ability to speak with her own voice.
Yet another biotech is facing a delay from the FDA as the agency reels from intense staffing cuts. | Yet another biotech is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results